Taficita Tablets Emtricitabine and Tenofovir Alafenamide 200mg/25mg

Product Overview

Taficita Tablets are a combination of Emtricitabine (200mg) and Tenofovir Alafenamide (25mg), both of which are antiretroviral medicines. Taficita is primarily used to treat HIV-1 infection in adults and adolescents, helping to lower the viral load and prevent the progression of the disease.

It is also used as part of pre-exposure prophylaxis (PrEP) in some treatment protocols to reduce the risk of acquiring HIV-1 infection.

Uses of Taficita Tablets

• Management of HIV-1 infection

• Reducing HIV viral load

• Pre-exposure prophylaxis (PrEP) for HIV prevention (as advised)

How Taficita Tablets Work

Taficita combines two nucleoside reverse transcriptase inhibitors (NRTIs) that block the reverse transcriptase enzyme essential for the HIV virus to multiply, thereby controlling infection and boosting immunity.

Side Effects of Taficita Tablets

Common side effects include:

• Nausea

• Headache

• Fatigue

• Diarrhea

• Dizziness

Rare but serious side effects may include liver problems and kidney issues. Regular monitoring is recommended.

Note: Always consult your doctor before starting or stopping Taficita.

Storage Instructions

• Store below 30?C

• Protect from light and moisture

• Keep out of reach of children

Precautions & Warnings

• Not recommended for individuals with known hypersensitivity to Emtricitabine or Tenofovir.

• Regular kidney and liver function tests may be required.

• Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.